Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Markku Saraheimo(Helsinki University Hospital), Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Jan Frystyk(Odense University Hospital), Allan Flyvbjerg(Aarhus University Hospital), Kim Pettersson-Fernholm(Helsinki University Hospital), Johan Fagerudd(Helsinki University Hospital), Anna‐Maija Teppo(Folkhälsans Forskningscentrum)
Cited by 130
Related Papers
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
|European Journal of Heart Failure|2016|561
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428